Feb 3, 2025 · Biegler included Blueprint among five potential biotech buyout candidates in a January 3 note. Blueprint was also among Wells Fargo’s 31 potential small- to mid-cap …

Feb 8, 2025 · Stock investors may look back at 2025 as the year of the takeover - one that delivered sizeable gains. "It's going to be a big year," Calamos Investments senior portfolio …

Oct 20, 2025 · Moderna (MRNA) shares have been volatile lately, drawing fresh attention as investors weigh the company’s prospects beyond COVID-19 vaccines. With its next earnings …

Feb 4, 2025 · Companies will keep their M&A focus on the strategic areas in which innovation and the potential for long-term growth align. In addition to GLP-1s, pharma’s high-growth areas …

Jan 27, 2025 · Explore the 2025 outlook for biopharma M&A trends, including key insights on deal-making fundamentals, market shifts, and strategic opportunities in the industry.

Dec 4, 2024 · Learn how to identify and evaluate potential acquisition targets with this comprehensive guide.

Using the AlphaSense platform, we dive into the biotech and pharma M&A landscape, including the headwinds and tailwinds affecting deals this year.

Oct 10, 2025 · Discover how M&A deal activity in 2025 will unfold, highlighting the biggest upcoming mergers and acquisitions. Explore the latest trends and major deals of the year.

The pharmaceutical, biopharmaceutical, and biotechnology industries are strategically focusing on high-potential sectors to align with evolving market demands and technological …

In light of this soundtrack of M&A momentum, here are five companies predicted to thrive even absent any acquisition offers. Investors should keep these names on their watchlists as …